Know When to Change a Patient's Home Osteoporosis Meds

The new Rx med, abaloparatide (Tymlos, TIM-lohs), will raise questions about evaluating osteoporosis meds in hospitalized patients....

Get unlimited access through an Enterprise license

Hospital Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals